Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Na Tang und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Science and Technology and State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 20121…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Physical Science and Technology and State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China.
- Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
- Shanghai Clinical Research and Trial Center, Shanghai 201210, China.
ORCID-Profile: Na Tang, Quanjiang Ji
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Tang, N., & Ji, Q. (2024). Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00247
Vancouver
Tang N, Ji Q. Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00247
BibTeX
@article{Tang2024,
author = {Tang, Na and Ji, Quanjiang},
title = {Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00247}
}
EUVIMED